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Birds are of great interest for a variety of research purposes, and
effective methods for manipulating the avian genome would
greatly accelerate progress in fields that rely on birds as model
systems for biological research, such as developmental biology and
behavioral neurobiology. Here, we describe a simple and effective
method for producing transgenic birds. We used lentiviral vectors
to produce transgenic quails that express GFP driven by the human
synapsin gene I promoter. Expression of GFP was specific to
neurons and consistent across multiple generations. Expression
was sufficient to allow visualization of individual axons and
dendrites of neurons in vivo by intrinsic GFP fluorescence. Tissue-
specific transgene expression at high levels provides a powerful
tool for biological research and opens new avenues for genetic
manipulation in birds.
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Transgenesis has proven to be one of the most powerful toolsfor modern biology (1). Genetic experiments using trans-
genic mice, fish, worms, and flies have revolutionized the study
of developmental biology, neurobiology, and immunology,
among other fields. Unfortunately, transgenic tools remain
unavailable for many popular research species. In particular,
useful transgenic birds have been difficult to produce, although
numerous attempts have been made for 25 years (2).
One major obstacle to genetic manipulation in birds has been
achieving reliable expression of the transgene. Foreign DNA can
be efficiently introduced into avian genomes by infecting the
early embryo with oncoretroviral vectors (3). A number of
groups have successfully produced transgenic chickens using this
general method (4, 5, 6). However, in transgenic birds produced
by using oncoretroviral vectors, transgene mRNA and protein
product are present at low or undetectable levels, possibly due
to developmental silencing (6).
Another class of retroviruses, the lentiviruses, is not silenced
during embryonic development. Transgenic mice and rats gen-
erated by using lentiviral vector show reliable transgene expres-
sion (7). Lentiviral vectors have also been used to generate
transgenic pigs and cattle (8, 9), and, in principle, they should
allow for the generation of transgenic birds. Indeed, promising
results were obtained in chickens with the use of recombinant
equine infectious anemia virus (EIAV), a type of lentivirus (10).
Transgenic chickens were generated that expressed GFP in some
tissues; however, the pattern of GFP expression was inconsistent
with the expected activity of the viral promoter used. Recently,
another study reported the use of HIV-1-based lentiviral vectors
to generate transgenic chickens that ubiquitously express GFP
under the control of the phosphoglycerol kinase (PGK) pro-
moter (11). Interestingly, the frequency of germ-line transmis-
sion among chicken founders reported in this study was 1%,
whereas the rate of transgenesis in mice is 80% (7). These
reports demonstrate the potential strengths of lentiviral vector-
based avian transgenesis. However, to be useful, both of the
following should apply: a system for the production of transgenic
birds should be efficient and gene expression should be predict-
able and reliably controlled by the regulatory sequences of the
transgene.
Here, we describe the efficient generation of transgenic birds
with neuron-specific expression using lentiviral vectors derived
from HIV-1. Vectors derived from HIV-1 have been shown to
allow faithful tissue-specific expression in transgenic mice (7).
To test whether lentiviral vectors could be used to direct
transgene expression specifically in neurons, we used the pro-
moter sequence from the human synapsin I gene (Hsyn). Len-
tiviral vectors engineered to contain Hsyn driving GFP were
introduced into Japanese quail embryos. This method produced
mosaic founder quails that expressed GFP in neurons and
transmitted the transgene to their progeny, which expressed high
levels of GFP selectively in neurons. In transgenic animals, the
axons and dendrites of developing neurons were easily detect-
able by fluorescence microscopy.
Our technique can be modified for use in other avian species
and can be used to alter the expression of endogenous genes.
Birds are important model organisms for many problems in
biology but are not more widely used because effective methods
for genetic manipulation in these animals do not exist. Lentiviral
transgenesis is a versatile and powerful tool that will provide a
molecular approach to studying biological questions in birds and
will make possible new avenues for research in a group of
popular research animals for which modern genetic techniques
were previously unavailable.
Methods
Construction of Lentiviral Vectors.We have developed a vector for
neuron-specific transgene expression based on FUGW, a self-
inactivating lentiviral vector derived from the HIV-1 (7). We
replaced the ubiquitin-C promoter region of FUGW with a
regulatory sequence that lies 570 to 93 bp from the tran-
scription start site of the Hsyn. The resulting construct is called
HsynGW (Fig. 1). Recombinant HsynGW virus was prepared
and stored as described (7). We titrated the virus on primary
cultures from newborn rat cortex and confirmed that GFP
expression in vitro was specific to neurons.
Production of Mosaic and Transgenic Quails. Freshly laid Japanese
quail (Coturnix coturnix japonica) eggs were purchased from
CBT Farms (Chestertown, MD) and arrived the next morning by
express courier. Eggs were placed on their sides for 1 h before
injection to allow the embryo to float to the top of the yolk.
Before windowing, egg shells were disinfected with 70% ethanol.
To gain access to the embryo, a 4-by-4-mm window was drilled
at the top of the eggshell with a handheld rotary tool (Dremel,
Mount Prospect, IL), and the shell membrane was removed with
forceps. Viral vector solution of HsynGW (107 infectious parti-
cles per microliter) was loaded into a pulled glass capillary
(Sutter Instruments, Novato, CA; o.d.  1 mm, i.d.  0.75 mm)
with a tip that had been scored with a ceramic tile (Sutter) and
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broken flush to 20 m o.d. Embryos were observed with a
dissecting microscope at 16 magnification, and 3 l of vector
solution was injected into the subgerminal cavity below the
embryo with an oil hydraulic injection system (CellTram oil,
Eppendorf). To allow visualization of the injection site, 5%
phenol red in PBS was added to the viral solution. Injections
were considered successful if the viral solution spread horizon-
tally in a circle below the embryo and if the perimeter of the viral
solution reached the borders of the area opaca (for a useful atlas
of avian embryo anatomy, see Bellairs and Osmond, ref. 12).
More than 90% of injections were successful according to these
criteria. After a successful injection, eggs were sealed to prevent
microbial contamination and fluid loss during incubation.
To seal the eggshell, a round glass coverslip was placed over
the shell window and was attached to the egg with a biocom-
patible silicone elastomer (Kwik-Cast, WPI Instruments,
Waltham, MA). Eggs were placed blunt end up into a forced air
incubator (Brinsea, Titusville, FL), with a temperature of 38°C
and a relative humidity of 45% until hatching, and were turned
periodically. Eggs hatched after 18 days of incubation and were
subsequently kept in a heated brooder. Three weeks later,
founder mosaic quails were placed in a cage until they reached
sexual maturity at 7 weeks, at which time they were mated to
wild-type quails. Eggs from transgenic founders were collected,
placed in the incubator, and examined at different stages of
development. Embryos were examined both with epif luorescent
and confocal microscopes. To genotype hatchlings, we nicked
the alar vein on the wing of 5-day-old animals and collected 70
l of blood.
Analysis of Transgene Copy Number and Expression Profile.Genomic
DNA from blood was extracted from whole blood samples by
overnight digestion in proteinase K followed by phenol chloro-
form extraction (13). DNA was digested with the restriction
enzyme PstI overnight at 37°C. PstI cuts once inside the inte-
grated provirus between the 5 viral LTR and the Hsyn promoter
(Fig. 1). Southern blot hybridization was performed with a
32P-labeled DNA probe against the GFP sequence.
To examine GFP expression, juvenile and adult quail were
transcardially perfused with 3% paraformaldehyde in PBS.
Brains were cut into 50-m sections on a vibrating microtome.
Sections were counterstained with Hoechst 33258 (Sigma–
Aldrich; 1.2 gml) for 5 min at room temperature, mounted in
50% glycerol, and examined under epif luorescence or with a
confocal f luorescent microscope. To examine whether GFP
expression was confined to neurons, we performed double
immunocytochemistry by incubating sections overnight at 4°C
with a Rabbit polyclonal anti-GFP antibody (Abcam, Cam-
bridge, MA ; dilution 1:1,000) andmouse monoclonal anti-NeuN
(Chemicon; dilution 1:500). Both antibodies were diluted in a
blocking solution containing 0.1% Triton X-100 and 10% nor-
mal goat serum. The next day, sections were washed with PBS
three times for 1 h each and incubated with a fluorescein-
conjugated anti-rabbit secondary antibody (Fl-1000, Vector
Laboratories) and a Texas red-conjugated anti-mouse antibody
(Ti-2000, Vector Laboratories) at room temperature for 1 h in
blocking solution. Finally, sections were washed with PBS three
times for 1 h each, mounted in 50% glycerol, and examined under
epif luorescence or with a confocal f luorescent microscope.
Results
Production of Mosaic Quails and Germ-Line Transmission of the
Transgene. Mosaic quails were produced by infecting the blasto-
discs of unincubated eggs with concentrated HsynGW lentiviral
vector. At this stage, the quail blastodisc is a thin sheet consisting
roughly of 40,000 cells. We infected 80 embryos with this
method, and, of these, 8 hatched and developed to adulthood.
Because the vector particles are too large to diffuse throughout
all layers of the blastodisc, this method infects only a percentage
of the cells of the embryo. Therefore, it is expected that these
founder quails will be mosaic for the presence of the transgene.
Accordingly, we expected only a percentage of the somatic tissue
of each quail to carry the transgene. To examine the expression
of the transgene in mosaic founders, we observed tissue sections
from two adult quails (50 days old).
In mosaic animals, GFP expression was confined to the
peripheral and central nervous system. In tissue sections from
the brain, we could observe GFP expression in the cell bodies of
neurons, axons, and dendrites. In particular, the dendritic fan
and soma of Purkinje cells of the cerebellum and the axons of
projection cells in the hippocampus were brightly f luorescent.
The neurons of the forebrain and optic tectum were also well
labeled. Although individual cell bodies were easily distin-
guished, the high density of labeled neurons made it difficult to
identify the processes of individual neurons. As expected, only a
percentage (10%) of neurons in the mosaic founders were
GFP-positive (data not shown).
To examine the transmission rate of the transgene to the
progeny, we bred six adult founder (F0) mosaics to wild-type
quails. The progeny of F0 mosaics were screened by Southern
Fig. 2. Transgenic animals carry single copies of the HsynGW provirus.
Southern blot analysis of genomic DNA from 23 progeny of Hsyn mosaic
founders. *, Lanewithmolecularweight standards (1-kb ladder, NewEngland
Biolabs). All other lanes contain genomic DNA from individual F1 quails.
Genomic DNA extracted from quail blood or embryos was digested with the
restriction enzyme PstI, which cuts once inside the lentiviral vector. The probe
used hybridizes to a 500-bp section of GFP. Transgenic birds were found to
carry only single copies of the integrated provirus as indicated by the presence
of a single band per lane on the Southern blot (lanes 1, 2, 7–13, and 18).
Fig. 1. Diagram of the relevant regions of the HsynGW vector used to
generate mosaic quails. The 5 CMV enhancer is used to express genomic viral
RNA during the production of vector particles but is excluded from the
integrated proviral DNA in the bird’s genome. The position of the restriction
site PstI used for Southernblot analysis of proviral integration is indicated. The
arrow located on top of the HSyn promoter box marks the start site of
transcription of EGFP. The woodchuck hepatitis virus posttranscriptional reg-
ulatory element (WRE) was included to increase the level of EGFP transcrip-
tion. TheU3 region of the viral 3 LTR (U3) contains a deletion thatminimizes
the endogenous transcriptional activity of the LTRs of the integrated provirus.
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blot analysis to test for the presence of the transgene (Fig. 2).
Germ-line transmission rate ranged between 8% and 33%,
depending on the founder (results are summarized in Table 1).
One founder mosaic did not produce any transgenic offspring.
Of the 16 transgenic offspring found, each carried a single copy
of the transgene (as assessed by Southern blotting).
Expression Pattern in F1 and F2 Transgenics.GFP expression was first
visible in transgenic embryos after 60 h of incubation. At this
time, GFP was visible in the soma of cells in the rostral spinal
cord and forebrain. GFP expression increased steadily through
early development. By 72 h of incubation, GFP fluorescence was
present in the axon and dendrites of cells in the brain and spinal
cord. After 4 days of incubation, individual neurons in the
forebrain of could be identified (see Fig. 4 A and B). Confocal
microscopy performed on the intact living embryo at this stage
revealed the axons and cell bodies of single neurons of the
forebrain (Fig. 4B). By embryonic day 6, the brain, spinal cord,
and peripheral nervous system showed strong GFP expression
(Fig. 3). The innervation of the limb buds was visible both in the
intact live embryo (Fig. 3A) and in tissue sections (Fig. 3D). The
eyes of the transgenic embryos were particularly well labeled
with GFP (Fig. 4 C and D). GFP expression in the retina was
visible through the pupil. In addition, axons innervating the iris
and cornea could be imaged easily in the live embryo (Fig. 4 C
andD). The observed temporal expression pattern of GFP in the
transgenic quails is similar to that of the endogenous synapsin
gene I in chicken embryos (14).
The level of GFP expression was comparable in 15 of 16 F1
transgenics. However, one embryo that carried a transgene copy
as assessed by Southern blot analysis did not display any detect-
able GFP expression. A positional effect may have been respon-
sible for the lack of expression in this animal, because the site of
transgene integration on a chromosome can exhibit strong
effects on transgene transcription (15).
Two transgenic quails (F1) carrying different insertions were
allowed to develop to sexual maturity. These quails were mated
with wild-type quails to determine whether GFP expression
levels and tissue specificity were consistent across multiple
generations. Progeny were screened by Southern blot analysis to
test for the presence of the transgene, and by fluorescence
microscopy to check for GFP expression. The transgene was
transmitted to F2 progeny at ratios that approached those
expected from the Mendelian inheritance of individual alleles:
59% (n  17) and 62% (n  8) for each parent, respectively.
Examination of embryonic, juvenile, and adult quails revealed
comparable spatial and temporal GFP expression pattern in F1
and F2 transgenics.
Tissue specificity in both F1 and F2 generations was examined
in whole-mount sections from day 6 embryos and in tissue
sections from the brains of juvenile and adult quails. GFP-
positive neurons were clearly visible throughout the brain, spinal
cord, and peripheral nervous system of transgenic animals, but
not in controls. Sections from the cerebral hemispheres, cere-
bellum, and optic tectum were processed for immunohistochem-
istry with antibodies against GFP and NeuN, a nuclear protein
specific for many types of mature neurons (16). No GFP-positive
cells were observed outside the central or peripheral nervous
system. NeuN was observed in the cell nuclei and perinuclear
cytoplasm of cells in the forebrain, cerebellum, and optic tectum.
All NeuN-positive cells expressed GFP, and most GFP-positive
cells were also labeled by NeuN (Fig. 5 A–C). Some cells, such
as Purkinje neurons of the cerebellum, were GFP-positive, but
not NeuN-positive (Fig. 5D). This result was expected because
some cell types, including Purkinje neurons, are not well labeled
by the NeuN antibody (16). However, wherever GFP-positive
cells were not also labeled with NeuN, cell morphology clearly
indicated that these GFP-labeled cells were neurons. The ob-
servation that GFP-expressing cells always had a neuronal
morphology, were labeled with the neuN antibody, and were
restricted to the nervous system demonstrates that transgene
expression was specific to neurons.
Discussion
In this study, we have demonstrated that lentiviral vectors can
be used to efficiently produce transgenic quails that express
Table 1. Germ-line transmission rates in mosaic and
transgenic quails
Generation
sex
No. of
progeny
examined
No. of
progeny
carrying
transgene
No. of
progeny
expressing
GFP
Germ-line
transmission
frequency, %
F0M 16 5 5 31
F0M 47 8 7* 17
F0M 12 1 1 8
F0M 35 0 0
F0F 12 4 4 33
F0F 4 1 1 25
F1M 17 10 10 59
F1M 8 5 5 62
M, male; F, female; F0, mosaic founder; F1, first generation transgenic.
*In one transgenic embryo GFP expression was not observed.
Fig. 3. GFP expression in an embryonic day 6 transgenic quail. (A) Profile
view of GFP expression in an intact embryo. Arrow indicates head; arrowhead
indicates spinal cord. GFP fluorescence in the retina can be seen through the
pupil. At this stage, the sensory andmotor innervation of the developing limb
buds begins to be visible (*). (B) GFP fluorescence in the brain and spinal cord.
(C) Merged view of fluorescence and bright field of the same embryo shown
inB. (D) Cross-sectional viewat the level of the forelimbs.Arrowhead indicates
the spinal cord. Arrow indicates a bundle of motoneuron axons innervating
the developing limb bud. The signal observed in the embryo’s ventral surface
(*) is due to autofluorescent signal originating from the skin. (E) Sagittal
section of three spinal ganglia (arrowheads). A short section of the spinal cord
labeled by GFP occupies the bottom left of the panel (arrow). Neurons are
labeled by intrinsic GFP fluorescence (green), and nuclei of all cells are labeled
by Hoechst 33258 (blue). (Scale bars: A, C, and D, 1 mm; E, 100 m.)
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GFP at high levels. Importantly, the transgene was expressed
selectively in neurons, a pattern we expected based on the
transcriptional activity of the synapsin promoter that we
engineered into our vector. Achieving the reliable spatial and
temporal expression pattern of a transgene is a critical step in
the development of transgenic technologies in birds. Our
vector contains two elements that we expect to contribute to
the faithful expression of GFP in neurons: a highly conserved
promoter and a recombinant viral backbone engineered not to
interfere with transgene expression.
For our promoter, we chose a region of the transcriptional
regulatory element of the Hsyn, an element known to produce
neuron-specific expression in vitro (17, 18). Although the avian
synapsin homolog has not been sequenced, the promoter region
for the synapsin I gene is highly conserved in several mammalian
species (19). In another study (11), the promoter region for
phosphoglycerol kinase was used to direct ubiquitous expression
in transgenic chickens. In contrast, previous studies with trans-
genic birds have often relied on viral promoters such as the SV40
promoter (4) and the CMV promoter (5). It is difficult to predict
the expression pattern of these promoters because they show no
similarity to any known endogenous promoter in birds. When a
lentiviral vector carrying the CMV promoter was used to pro-
duce transgenic chickens, transgene expression was primarily in
the pancreas and to a lesser extent in the liver, skin, muscle, and
lining of the intestine (10). In addition, the level of transgene
expression in these tissues was variable between different trans-
genic lines.
In addition to the promoter used, the viral backbone can also
affect transgene expression. Viral sequences of retroviral-based
vectors have been shown to affect gene expression in two ways.
(i) Oncoretroviral elements and associated sequences are si-
lenced during development by de novo methylation of cytosine
residues. Methylation stimulates the formation of heterochro-
matin, which blocks the transcriptional activity of the region
surrounding the integrated retrovirus, and ultimately results in
low or undetectable levels of transgene expression. This effect
had been clearly documented in mice (20), and there is evidence
suggesting this effect may also occur in birds (6). (ii) Retroviral
LTRs contain internal promoters and enhancers, which may
interfere with the expression of the transgene in both oncoret-
roviral and lentiviral based vectors. The vector used in our study
has been engineered to minimize the transcriptional activity of
the LTRs (21), and it was shown to faithfully allow tissue-specific
transgene expression without developmental silencing (7). Thus,
recombinant HIV-derived lentiviral vectors are an effective
vector to allow tissue-specific expression in both transgenic
mammals and birds.
We chose quails as a bird model for transgenesis because of
their widespread use in developmental studies and for a number
of practical reasons (22). Quails are excellent breeders, require
less space to house than chickens, and develop rapidly. Incuba-
tion lasts 18 days, and hatchlings become sexually mature after
7 weeks. Eggs are easy to obtain from farms by mail so it is not
necessary to maintain a breeding colony solely to produce eggs
for the generation of mosaics. Transgenics of other avian species
would require more time and space to breed. Because the
organization of the avian embryo is well conserved at the time
of oviposition, we do not anticipate any major obstacles to the
generation of transgenics in other species, as suggested by
previous experiments in chickens (10, 11).
Transgenesis with lentiviral vectors will allow for the molec-
ular dissection of physiological processes in birds with a level of
precision unattainable with other methods. Lentiviral transgen-
esis can be used to interfere with normal gene expression in a
Fig. 4. Imaging of GFP-expressing neurons in live embryos. (A) GFP-
expressing neurons in the brain of embryonic day 4 transgenic quail at low
magnification. Arrowhead indicates regionmagnified inB. (B) Cell bodies and
axons of GFP-labeled neurons in a live embryo, viewed by confocal micros-
copy. (C) Eye of live embryonic day 6 quail. Arrow indicates GFP-positive retina
viewed through the pupil. Arrowhead indicates axons innervating the cornea
and iris. (D) Individual axon innervating the cornea, viewed by confocal
microscopy. (Scale bars: A and C, 250 m; B and D, 10 m.)
Fig. 5. Selective expression of GFP in neurons from HsynGFP transgenic
quails. Shown is immunohistochemistry against GFP (A) and neuron-specific
marker NeuN (B) in sections from the forebrain of transgenic quails. (C) A
merged image ofA and B. Immunohistochemistrywas performed against GFP
because intrinsic GFP fluorescence fades after fixation. Tissue sections were
viewed with a confocal microscope. (B) NeuN staining was observed in the
nuclei and perinuclear cytoplasm of neurons. Neuron processes were labeled
only by GFP (see arrow in A). In most cases, GFP-positive cell bodies were also
NeuN-positive (exemplary cells are marked by arrowheads in A, B, and C).
Some cells with neuronmorphology (i.e., bearing axons and dendritic arbors),
such as the Purkinje cells of the cerebellum (D), were GFP-positive, but not
NeuN-positive. This result was expected because previous works have shown
that NeuN antibodies do not label all neurons. (Scale bar: 10 m.)
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number of ways. (i) Genes of interest can be ectopically ex-
pressed to modify the development or function of cells. (ii)
Dominant-negative constructs can be introduced to block nor-
mal gene function (23). (iii) Lentiviral vectors carrying short
interfering RNAs (siRNAs) can down-regulate endogenous
mRNAs and can be used against genes for which no dominant
negative constructs are known (24). These powerful manipula-
tions make lentiviral transgenesis a useful genetic tool to study
complex biological processes in birds.
For our initial experiments we chose a marker that enables the
visualization of individual neurons in the developing embryo.Using
the Hysn promoter to drive expression of GFP in the neurons of
quails, we were able to label individual cells beginning 60 h after
incubation. By 72 h, GFP had diffused into and labeled the
dendrites and axons of neurons in the forebrain and spinal cord.
Because their neurons are well labeled and because of the early age
at whichGFP expression begins, these birds will be useful for in vivo
imaging studies of neural development. Strains of transgenic mice
with neuron-specific GFP expression have been valuable for in vivo
studies of synaptogenesis and neuromuscular junction development
(25). However, imaging mouse pups during embryonic develop-
ment is difficult because themothermust be killed and offspring do
not survive long outside the womb. The study of embryonic
development is easier in birds than in mammals, because the avian
embryo can be continuously viewed over hours and days both in the
shell and in artificial culture systems. Current techniques for in vivo
imaging in chick embryos require the injection of dyes or electro-
poration of plasmids (26), but these invasive techniques can disrupt
normal development. Transgenic or mosaic birds could offer a
powerful advantage in experiments where current methods of cell
labeling cannot be used.
We anticipate that avian transgenesis would be particularly useful
for the study of behavioral neurobiology. Experiments with trans-
genic, mutant, and knock-out mice have been extremely valuable in
studying the molecular basis of instinctual behavior as well as
learning and memory (27). However, for the study of many
behaviors, avian species are the preferred model organisms. Avian
species exhibit a wide range of well studied behaviors, such as food
hoarding (28), filial imprinting (29), sound localization (30), and
vocal learning (31). Transgenesis with lentiviral vectors will allow
for the precise molecular dissection of these behaviors.
In addition to its use in basic science research, avian trans-
genesis has potential commercial applications, specifically in the
production of therapeutic proteins. Transgenic birds generated
by using oncoretroviral vectors have been shown to express low
levels of transgene in the egg whites of laid eggs (32). The chicken
ovalbumin promoter has been suggested as a regulatory se-
quence for directing protein expression in egg whites (33). Using
lentiviral vectors containing the ovalbumin promoter, transgenic
chickens could be engineered to produce high levels of thera-
peutic protein in their egg whites, providing a high-yield source
of biopharmaceuticals.
In summary, we have developed a method for the generation of
transgenic animals with tissue-specific expression in a group of
species for which genetic experiments were previously not feasible.
Although birds have historically been useful for studying many
important problems in development and neurobiology (34, 35),
research in mice (and in other animals in which genetic and
molecular experiments are possible) has dominated these fields.
However, for many questions in biology, avian species remain the
model organisms of choice. We anticipate that lentiviral transgen-
esis will greatly improve our ability to study these questions and will
be an asset to the growing field of avian genetics (36).
B.B.S. thanks A. Stolfi for assistance with egg injections and H. Y. Chung
and L. Smith for help with figures.
1. Jaenisch, R. (1988) Science 240, 1468–1474.
2. Sang, H. (2004) Mech. Dev. 121, 1179–1186.
3. Bosselman, R. A., Hsu, R. Y., Boggs, T., Hu, S., Bruszewski, J., Ou, S., Kozar,
L., Martin, F., Green, C., Jacobsen, F., et al. (1989) Science 243, 533–535.
4. Mozdziak, P. E., Borwornpinyo, S., McCoy, D. W. & Petitte, J. N. (2003) Dev.
Dyn. 226, 439–445.
5. Harvey, A. J., Speksnijder, G., Baugh, L. R., Morris, J. A. & Ivarie, R. (2002)
Poultry Sci. 81, 202–212.
6. Mizuarai, S., Ono, K., Yamaguchi, K., Nishijima, K., Kamihira, M. & Iijima, S.
(2001) Biochem. Biophys. Res. Commun. 286, 456–463.
7. Lois, C., Hong, E. J., Pease, S., Brown, E. J. & Baltimore, D. (2002) Science
295, 868–872.
8. Hofmann, A., Kessler, B., Ewerling, S., Weppert, M., Vogg, B., Ludwig, H.,
Stojkovic, M., Boelhauve, M., Brem, G., Wolf, E. & Pfeifer, A. (2003) EMBO
Rep. 4, 1054–1060.
9. Hofmann, A., Zakhartchenko, V., Weppert, M., Sebald, H., Wenigerkind, H.,
Brem, G., Wolf, E. & Pfeifer, A. (2004) Biol. Reprod. 71, 405–409.
10. McGrew, M. J., Sherman, A., Ellard, F. M., Lillico, S. G., Gilhooley, H. J.,
Kingsman, A. J., Mitrophanous, K. A. & Sang, H. (2004) EMBO Rep. 5,
728–733.
11. Chapman, S. C., Lawson, A., Macarthur, W. C., Wiese, R. J., Loechel, R. H.,
Burgos-Trinidad, M., Wakefield, J. K., Ramabhadran, R., Mauch, T. J. &
Schoenwolf, G. C. (2005) Development 132, 935–940.
12. Bellairs, R. & Osmond, M. (1998) The Atlas of Chick Development (Academic,
San Diego).
13. Sambrook, J. & Russel, D. W. (2001)Molecular Cloning: A Laboratory Manual
(Cold Spring Harbor Lab. Press, Woodbury, NY).
14. Plateroti, M., Vignoli, A. L., Biagioni, S., Di Stasi, A. M., Petrucci, T. C. &
Augusti-Tocco, G. (1994) J. Neurosci. Res. 39, 535–544.
15. Kioussis, D. & Festenstein, R. (1997) Curr. Opin. Genet. Dev. 7, 614–619.
16. Mullen, R. J., Buck, C. R. & Smith, A. M. (1992) Development 116, 201–211.
17. Thiel, G., Greengard, P. & Sudhof, T. C. (1991) Proc. Natl. Acad. Sci. USA 88,
3431–3435.
18. Sauerwald, A., Hoesche, C., Oschwald, R. & Kilimann, M. W. (1990) J. Biol.
Chem. 265, 14932–14937.
19. Schoch, S., Cibelli, G. & Thiel, G. (1996) J. Biol. Chem. 271, 3317–3323.
20. Jahner, D., Stuhlmann, H., Stewart, C. L., Harbers, K., Lohler, J., Simon, I. &
Jaenisch, R. (1982) Nature 298, 623–628.
21. Miyoshi, H., Blomer, U., Takahashi, M., Gage, F. H. & Verma, I. M. (1998)
J. Virol. 72, 8150–8157.
22. Padgett, C. A. & Ivey, W. D. (1959) Science 129, 267–268.
23. Herskowitz, I. (1987) Nature 329, 219–222.
24. Tiscornia, G., Singer, O., Ikawa, M. & Verma, I. M. (2003) Proc. Natl. Acad.
Sci. USA 100, 1844–1848.
25. Feng, G., Mellor, R. H., Bernstein, M., Keller-Peck, C., Nguyen, Q. T., Wallace,
M., Nerbonne, J. M., Lichtman, J. W. & Sanes, J. R. (2000) Neuron 28, 41–51.
26. Niell, C. M. & Smith, S. J. (2004) Annu. Rev. Physiol. 66, 771–798.
27. Chen, C. & Tonegawa, S. (1997) Annu. Rev. Neurosci. 20, 157–184.
28. Clayton, N. S. & Dickinson, A. (1998) Nature 395, 272–274.
29. Horn, G. (2004) Nat. Rev. Neurosci. 5, 108–120.
30. Konishi, M. (2003) Annu. Rev. Neurosci. 26, 31–55.
31. Nottebohm, F. (1999) in The Design of Animal Communication, eds. Hauser,
M. D. & Konishi, M. (MIT Press, Cambridge), pp. 63–110.
32. Harvey, A. J., Speksnijder, G., Baugh, L. R., Morris, J. A. & Ivarie, R. (2002)
Nat. Biotechnol. 20, 396–399.
33. Ivarie, R. (2003) Trends Biotechnol. 21, 14–19.
34. Konishi, M., Emlen, S. T., Ricklefs, R. E. &Wingfield, J. C. (1989) Science 246,
465–472.
35. Stern, C. D. (2005) Dev. Cell 8, 9–17.
36. Brown, W. R., Hubbard, S. J., Tickle, C. &Wilson, S. A. (2003)Nat. Rev.Genet.
4, 87–98.
Scott and Lois PNAS  November 8, 2005  vol. 102  no. 45  16447
N
EU
RO
SC
IE
N
CE
